The team at PedersoliGattai is seen as ‘very knowledgeable about biotech practices in Italy and Europe’. Nicola Brunetti and Enrico Candotti advise on investments in biotech companies. Licia Garotti focuses on AI-driven projects, distribution agreements, complex patent disputes, and drafting and negotiating commercial agreements.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Testimonials
Collated independently by Legal 500 research team.
- ‘This team is very knowledgeable about biotech practices in Italy and Europe.’
- 'We work closely with Enrico Candotti and Nicola Brunetti for corporate-related matters. They have excellent knowledge of investment agreements and matters related to corporate. They also acquired good knowledge in interacting with foreign lawyers/investors when implementing investment agreements that foresee investments from parties outside of Italy, including Golden Power clearance.’
- ‘Very efficient and time sensitive. Good reputation and reliability.’
- ‘Multi-competencies under one roof. Careful day-by-day follow-up of corporate affairs.’
- ‘Strong technical competence, personalised service, and multidisciplinary functions.’
- ‘The team is reliable.’
Key clients
- Advanced Sterilization Products Italia
- General Medical Merate S.p.A
- Catalent Inc
- Maravai Lifesciences
- Sofinnova Biovelocita II S.L.P.S
- H14 S.p.A
- Genespire S.r.l
- Ardian
- Omega Pharma S.r.l
- Turenne Santé
- Eurazeo
- Bnp Paribas Bnl Equity Investments
Other key lawyers
Enrico Candotti; Licia Garotti; Nicola Brunetti
